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Abstract: Epidural steroid injection (ESI) represents a popular treatment option in patients with lumbar
degenerative disc disease (DDD). The main objective of the article was to determine whether the 6-minute
walking test (6WT) could assist in the discrimination between ESI responders and nonresponders. We
used a validated 6WT smartphone application to assess self-measured objective functional impairment
(OFI) in 3 patients with DDD undergoing ESI. Patient-reported outcome measures (PROMs), including
the Core Outcome Measures Index and the Oswestry Disability Index, were obtained at baseline and at
the 3-, 7-, and 28-day follow-up. Descriptive analyses were used to compare PROMs with OFI over time.
Two patients responded well to the ESI, illustrated by clinically meaningful improvements in PROMs.
This improvement was accompanied by a substantial increase in the 6WT distance (case I: 358 m vs.
517 m and case II: 296 m vs. 625 m). One patient reported only moderate improvement in leg pain
and conflicting results in the other PROMs. The 6WT demonstrated a persistent OFI (487 m vs. 488
m). This patient was considered a nonresponder and underwent surgical treatment. This case series
illustrates the feasibility of the smartphone-based 6WT as a tool to assess OFI in patients undergoing
ESI for lumbar DDD.
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Epidural steroid injection (ESI) represents a popular treatment option in patients with lum-
bar degenerative disc disease (DDD). The main objective of the article was to determine 
whether the 6-minute walking test (6WT) could assist in the discrimination between ESI 
responders and nonresponders. We used a validated 6WT smartphone application to assess 
self-measured objective functional impairment (OFI) in 3 patients with DDD undergoing 
ESI. Patient-reported outcome measures (PROMs), including the Core Outcome Measures 
Index and the Oswestry Disability Index, were obtained at baseline and at the 3-, 7-, and 
28-day follow-up. Descriptive analyses were used to compare PROMs with OFI over time. 
Two patients responded well to the ESI, illustrated by clinically meaningful improvements 
in PROMs. This improvement was accompanied by a substantial increase in the 6WT dis-
tance (case I: 358 m vs. 517 m and case II: 296 m vs. 625 m). One patient reported only 
moderate improvement in leg pain and conflicting results in the other PROMs. The 6WT 
demonstrated a persistent OFI (487 m vs. 488 m). This patient was considered a nonre-
sponder and underwent surgical treatment. This case series illustrates the feasibility of the 
smartphone-based 6WT as a tool to assess OFI in patients undergoing ESI for lumbar DDD.
Keywords: Lumbar disc herniation, Objective functional impairment, Epidural steroid in-
jection
INTRODUCTION
A thorough evaluation of functional impairment is essential 
to critically assess outcome and treatment efficacy in patients 
undergoing surgical or conservative treatment for lumbar de-
generative disc diseases (DDDs). Traditionally, patient-reported 
outcome measures (PROMs) in the form of questionnaires are 
deployed to assess a patient’s subjective well-being, pain level, 
and impairment. More recently, several measures of objective 
functional impairment (OFI) have been described in the litera-
ture with the aim to complement PROMs by contributing an 
objective outcome dimension to the comprehensive patient 
evaluation.2
Despite the growing number of publications in this field, to 
date there is no shared “gold standard” for the objective assess-
ment of patients suffering from DDD.1 The majority of described 
objective measures, for example, the motorized-treadmill-test 
or the self-paced walk test, require considerable resources in-
cluding specific equipment, trained personal and time commit-
ment.2,3 Few objective outcome measures exist that can be self-
performed by the patient without supervision. The 6-minute 
walking test (6WT) was identified as a promising tool in a re-
cent systematic review of objective outcomes in spinal surgery.1 
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veloped to be utilized by spine patients in their home environ-
ment.4
To date, there have been no reports on the use of the 6WT as 
an objective, self-measured functional assessment in patients 
undergoing lumbar interlaminar or transforaminal epidural 
steroid injection (ESI) for DDD. ESI represents a frequently per-
formed nonsurgical management option in DDD even though 
its therapeutic benefits are debated and the diagnostic informa-
tion gained from the procedure remains controversial.5-7 Wheth-
er or not a patient experienced a positive response to ESI remains 
difficult to determine in some settings. The 6WT may prove 
useful in identifying ESI responders and nonresponders. This 
case series presents the first experience gained while using the 
6WT app in patients undergoing ESI for lumbar DDD. We com-
pare changes in the 6WT with established PROMs and discuss 
the added diagnostic benefit of the 6WT.
MATERIALS AND METHODS
1. Patient Identification
We recruited 3 consecutive patients (>18 years) scheduled to 
undergo transforaminal or interlaminar ESI due to lumbar DDD 
at the Kantonsspital St. Gallen, Switzerland, between August 
and September 2019. There were no drop-outs and none of the 
3 patients failed to complete the follow-up. All patients were 
treated according to local clinical standards.
2. Subjective Outcome Assessment
Patient was asked to fill out PROM questionnaires, including 
the core outcome measures index (COMI) back8 and the Os-
westry Disability Index (ODI)9 before the intervention and at 
the 28-day follow-up. Participants additionally documented 
their leg pain on a numeric rating scale (NRS; range from 0 [no 
pain] to 10 [maximum pain]) for 7 consecutive days following 
the intervention using a pain diary. At the 28-day follow-up, the 
treating neurosurgeons evaluated the overall treatment response 
during a face-to-face outpatient consultation.
3. Assessment of OFI
Previously known to assess cardiovascular health, the 6WT 
determines restrictions in maximum walking capacity. The test’s 
main result is a function of the maximum distance in meters 
(m) a person can walk in 6 minutes (the 6-minute walking dis-
tance, 6WD). In patients with lumbar DDD, pain and function-
al restrictions frequently lower the maximum 6WD, as patients 
might ambulate slower or have to take breaks in order to allevi-
ate symptoms of leg and back pain. To assess OFI, patients were 
instructed to use the recently developed free 6WT smartphone 
app in their home environment. This spine-specific 6WT app 
was demonstrated to be highly reliable in settings that resemble 
a patient’s home environment.4
At first consultation, the 6WT app was downloaded from the 
Google Play Store or Apple Store (link to the 6WT app: see Sup-
plementary material) onto the patient’s smartphone (Fig. 1). Pa-
tients received detailed instructions by their treating neurosur-
geon prior to using the app. They consented that the app would 
measure the 6WD by accessing their smartphone’s global posi-
tioning system coordinates. Patients were instructed to select a 
sufficiently long (around 700 m), flat and level environment 
within their neighborhood, since app-based 6WD measure-
ments had optimal reliability under those circumstances.4 Pa-
tients were then instructed to perform the 6WT twice at 4-time 
Fig. 1. The 6-minute walking test smartphone application. By 
pressing the “Play” button, the application starts measuring a 
patient’s distance walked within 6 minutes as main outcome 
using GPS (global positioning system) coordinates. Both dis-
tance and time are displayed on the screen while walking. In 
this example, the measurement is at 1:28 minutes and 122 m 
and still ongoing. After 6 minutes, the measurement stops au-
tomatically. By pressing the “Archive” button on the upper 
right corner, completed measurements are captured with a 
date and time stamp.
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points: (1) prior to the ESI, (2) at 3 days, (3) at 7 days, and (4) at 
28 days after the intervention. The mean 6WD of both mea-
surements for each time point was used.
4. Injection Technique
For transforaminal ESI, a 25-gauge spinal needle was used to 
advance toward the targeted intervertebral foramen under an-
teriorposterior fluoroscopic imaging. When the position lateral 
to the inferior margin of the targeted pedicle was reached, io-
dinated contrast (Iopamiro, Bracco Suisse SA, Geneva, Switzer-
land) was instilled under real-time fluoroscopy. A mixture of 2 
mL of bupivacaine (0.75%) and 1-mL mephameson (4 mg/mL) 
was used for ESI, in accordance with our institutional policy.10 
The patients were discharged on the same day.
For interlaminar ESI, patients were positioned prone with 
mild lumbar kyphosis to increase the interlaminar space. Fluo-
roscopic anteriorposterior imaging was used to identify the tar-
geted vertebral level. First, local anesthesia with rapidocain (1%) 
was applied. Then, a 17-G spinal needle was advanced parallel 
to the image trajectory until encountering loss of resistance af-
ter penetrating the ligamentum flavum under continuous saline 
injection. Subsequently, iodinated contrast (Iopamiro) was in-
jected to confirm epidural placement. Once optimal contrast 
distribution was seen, 2-mg diprophos and 5-mL lidocain (1%) 
were instilled into the epidural space. Following the procedure, 
patients routinely underwent monitoring for 2 hours before be-
ing discharged.
5. Statistical Analysis
Due to the small sample size, no statistical tests were applied 
but descriptive analyses were chosen. OFI by the 6WD was in-
terpreted according to age-specific normal population refer-
ence values (31–50 years: 624± 83 m [95% confidence interval, 
604–643; n= 70]; 51–70 years: 573± 92 m [556–590, n= 120]; 
> 71 years: 438± 130 m [381–496, n= 22]; unpublished data). 
Change in the PROMs was considered clinically meaningful if 
it corresponded to at least the minimum clinically important 
difference (MCID) of each outcome measure, namely 1.7 on 
the NRS for leg pain, 14.3 on the ODI11 and 1.20 for the COMI.12
6. Ethical Considerations
All procedures performed in studies involving human partic-
ipants were in accordance with the ethical standards of the in-
stitutional and/or national research committee and with the 
1964 Helsinki declaration and its later amendments or compa-
rable ethical standards. The collection and publication of data 
were permitted by the local ethic committee (Kantonale Ethik-
kommission, EKOS - 2019-01209). All patients provided writ-
ten informed consent prior to the initiation of the data collec-
tion.
CASE REPORTS
Three consecutive cases are presented to illustrate agreement 
between PROMs and OFI in treatment responders and nonre-
sponders.
1. Case 1
A 54-year-old otherwise healthy male presented to our emer-
gency clinic with a 2-week history of sudden onset of right-sid-
ed pain on the dorsolateral thigh and calf (NRS, 8/10; ODI, 
18/100; COMI, 7.4/10). He additionally reported numbness in 
his lateral thigh and calf. The pain was aggravated while walk-
ing and standing, and with 296 m his baseline 6WD was well-
Fig. 2. (A, B) Axial and sagittal magnetic resonance images of 
case 1. (C) The 6-minute walking distance (6WD) in meters 
before and after the lumbar epidural steroid injection (ESI) is 
displayed on the left x-axis. Changes in the numeric rating 
scale (NRS) are plotted on the right x-axis. (D, E) The core 
outcome measures index back (COMI) and the Oswestry Dis-
ability Index (ODI) are shown before the ESI and at the 4-week 
follow-up.
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below the age-adjusted norm. Physical examination was unre-
markable except for hypesthesia along the L5 dermatome. Lum-
bar spine magnetic resonance imaging (MRI) revealed a broad-
based L4/5 disc protrusion with consecutive L5 nerve compres-
sion (Fig. 2A, B). After 4 weeks of conservative treatment with-
out sufficient pain relief, the patient underwent a right-sided L5 
transforaminal ESI.
At the 4-week follow-up, the patient described a clinically 
meaningful relief of his leg pain (NRS, 3/10; Fig. 2C) and subjec-
tive back-related disability measure (ODI, 6/100; Fig. 2E). Inter-
estingly, the COMI decreased only by 1.1 points, thus failing to 
reach a clinically meaningful difference (Fig. 2D). However, the 
patient had been able to discontinue using opioids and had re-
turned to work. His self-reported improvement at this time was 
reflected by a normalization of his 6WD (625 m; Fig. 2C).
2. Case 2
A 62-year-old male presented at our outpatient clinic with a 
4-month history of progressive neurogenic claudication (NRS 
leg pain, 7/10; ODI, 20/100; COMI, 7/10). He additionally com-
plained of diffuse weakness in his right leg. Physical examina-
tion showed a mild paresis of his right iliopsoas muscle (4/5). 
Lumbar MRI revealed a discoligamentous lumbar spinal steno-
sis at L3/4 with predominantly right-sided L4 nerve compres-
sion (Fig. 3A, B). The patient was not taking any pain medica-
tion but felt limited in his activities of daily living due to the ex-
ercise-dependent pain and weakness in his right leg. Corre-
spondingly the 6WD (358 m) was well-below the age-specific 
norm. The patient underwent an interlaminar ESI at L3/4.
At the 4-week follow-up, the patient reported a complete re-
mission of his neurogenic claudication and muscle weakness. 
This was reflected by an increase in 6WD to 517 m 4 weeks af-
ter ESI, approaching his age-specific normal population range 
(Fig. 3C). Additionally, we observed a parallel, clinically mean-
ingful decrease in both the ODI (7/100) and COMI (0.2/10) 
(Fig. 3D, E).
Fig. 3. (A, B) Axial and sagittal magnetic resonance images of 
case 2. (C) The 6-minute walking distance (6WD) in meters 
before and after the lumbar epidural steroid injection (ESI) is 
displayed on the left x-axis. Changes in the numeric rating 
scale (NRS) are plotted on the right x-axis. (D, E) The core 
outcome measures index back (COMI) and the Oswestry Dis-
ability Index (ODI) are shown before the ESI and at the 
4-week follow-up.
Fig. 4. (A, B) Axial and sagittal magnetic resonance images of 
case 3. (C) The 6-minute walking distance (6WD) in meters 
before and after the lumbar epidural steroid injection (ESI) is 
displayed on the left x-axis. Changes in the numeric rating 
scale (NRS) are plotted on the right x-axis. (D, E) The core 
outcome measures index back (COMI) and the Oswestry Dis-
ability Index (ODI) are shown before the ESI and at the 4-week 
follow-up.
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3. Case 3
A 56-year-old male presented to our outpatient clinic with 
progressive right-sided lumbar pain radiating to the lateral thigh 
and malleolus lateralis (NRS, 6/10; ODI, 12/100; COMI, 5.7/10). 
The leg pain had started 2 weeks prior without preceding trau-
ma. His pain was aggravated by standing and walking; his mean 
6WD was below his normal population reference (487 m). The 
patient had undergone right-sided L4/5 sequestrectomy due to 
disc herniation 13 months prior and had been pain free until 
this new pain episode started. The physical examination was 
unremarkable. Lumbar spine MRI showed a right-sided L4/5 
recurrent disc herniation compromising the L5 nerve in the in-
tervertebral recess (Fig. 4A, B). As his symptoms worsened de-
spite conservative treatment, he received a right L5 transforam-
inal ESI.
The patient reported a moderate pain relief from to NRS 4 
leg pain (just surpassing the MCID) at 4 weeks (Fig. 4C). Anal-
ysis of the 6WD over time showed a slight decrease immediate-
ly after the intervention and no substantial improvement at the 
28-day follow-up (Fig. 4C). PROMs provided conflicting re-
sults: while his ODI increased during follow-up (13/100; Fig. 
4E), his COMI showed minor, yet not clinically meaningful im-
provement (4.6/10; Fig. 4D). The patient was not satisfied with 
his clinical situation and functional level despite the ESI (= non-
responder). He signed up for L4/5 sequestrectomy shortly after.
DISCUSSION
This case series represents the first account on the use of the 
6WT smartphone app as a tool to assess OFI before and after 
ESI in patients with DDD. It provides preliminary evidence that 
the self-assessment of OFI in a patient’s home environment is 
feasible and provides additional information to the physician. 
The combination of subjective PROM-based and objective app-
based OFI assessment support the clinician to evaluate whether 
or not a patient has responded positively to a healthcare inter-
vention.
We observed that the 6WT served as a good indicator for 
change in a patient’s functional status after ESI, also reflected by 
the PROMs. The first 2 cases reported marked and clinically 
meaningful improvements in PROMs, including ODI, COMI, 
and NRS leg pain. This was in line with a substantial increase in 
their 6WD after ESI, approaching or exceeding the age-specific 
normal population reference values. Interestingly, both patients 
showed a progressive improvement in walking capacity with 
increasing 6WD already after 3 and 7 days, which continued to 
improve until the 28-day follow-up. As the anti-inflammatory 
effect of the steroids effectively lowered a patient’s pain and dis-
ability level, the 6WD increased. The longitudinal improvement 
in 6WD, therefore, indicates a good responsiveness of the 6WT 
to detect change in OFI.
In contrast, the patient in the case vignette III did not benefit 
from the ESI, according to the lack of improvement in his 6WD. 
The patient experienced a moderate pain relief just above the 
MCID; however, this did not translate into a detectable improve-
ment in OFI reflected by the 6WD. Furthermore, the subjective 
functional status worsened after ESI according to ODI while 
the COMI showed minor, yet not clinically significant improve-
ments. With the conflicting results of the battery of PROMs, 
the objective evaluation of walking capacity using the 6WT app 
provided meaningful and quantifiable additional information 
with impact on the patient’s daily activities to complement the 
subjective evaluation.
The smartphone-based approach was feasible in our clinical 
practice and was associated with a low responder burden. Orig-
inally designed for the use in cardio-pulmonary diseases, the 
simple and reliable nature of the 6WT has made it an attractive 
tool for monitoring patients with a broad range of medical con-
ditions.13-15 While the 6WT has not yet been systematically vali-
dated in spine patients, one major benefit of the spine-specific 
6WT app is that specialized equipment other than a smartphone 
is not required. All 3 patients felt that the app was easy to use 
and that the 6WT was even better suited to detect changes in 
their functional status and symptoms when compared to the 
PROM questionnaires. Smartphone-based measures can be 
collected longitudinally and repetitively, allowing patients to 
detect and objectify change in their functional status over time. 
The good acceptance by patients and the high reliability of app-
based 6WT measurements may be an interesting asset to future 
clinical studies or trials.16 This small series, together with previ-
ously published reports on smartphone-based assessment tools 
in other neurological diseases,16,17 suggests that digital outcome 
measures represent a promising avenue to enable a comprehen-
sive assessment of functional outcome in both research and clin-
ical practice. While the distance walked within a certain time 
frame is an important measure of function, spine patients also 
regularly show impaired gait pattern. Therefore, comparing 6WT 
measurements with more detailed gait analysis by means of shoe 
insert sensors might be of additional interest in future studies. 
One disadvantage of smartphone applications as objective out-
come measurement for spinal pathologies might be the exclu-
sion of a percentage of the elderly population without smart-
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phones. While this share might further shrink with the ongoing 
digital transformation, a lack of knowledge in using smartphone 
apps within the elderly might currently serve as an additional 
barrier for their successful use.17 Both of these drawbacks are 
likely to vanish over time, as the digitalization of the society con-
tinues.
The main limitation of this case series is its small sample size, 
which prevents meaningful statistical analysis. Further investi-
gations to assess the validity and sensitivity of the 6WT, as well 
as the 6WT’s ability to detect changes in functional capacity of 
patients undergoing spine surgery or ESI, are warranted in ade-
quately powered studies. The definition of the 6WT’s “clinically 
meaningful change of function” (= MCID) will be crucial for 
its implementation as a standardized and validated outcome in-
strument. In cardiovascular conditions, a mean change between 
43–54 m has been reported as clinically significant previously, but 
disease-specific MCIDs for the spine must still be determined.19,20 
In addition, future research should focus on cross-validating 
6WD results with PROMs, such as NRS leg pain, COMI, and 
ODI.
CONCLUSION
This patient series suggests that the 6WT is a useful tool to 
assess outcome and monitor a patient’s functional walking ca-
pacity before and after lumbar ESI. Our report further demon-
strates that self-measurements of the 6WT are feasible in clini-
cal practice and are well-accepted by patients.
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SUPPLEMENTARY MATERIALS
Link to the free 6WT smartphone application: 1. Android 
Google Play Store: https://play.google.com/store/apps/details?id 
= ch.webgearing.walkingapp&hl= de. 2. Apple App Store: https: 
//apps.apple.com/de/app/6wt-app/id1454002232.
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